SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Intellia Therapeutics Reports Third-Quarter Results and Business Updates

The company said it remains on track with lonvo-z commercial readiness efforts ahead of a March 10, 2027 PDUFA date.

NTLA

Story updates

01:04:34 PM UTC
SquawkNews
Intellia Therapeutics 3Q Rev $7.16M >NTLA

Related stories